Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04656964Completed
Randomised, double-blind trial of remimazolam in Procedural sedation (PS) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Recovery time after operation at Day 0. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04656964.